Developing Growth Fund
Daily price w/o sales charge as of 09/24/2020
$25.23
$0.23
YTD Returns w/o sales charge as of 09/24/2020
28.53%
Overall Morningstar RatingsSmall Growth
as of 08/31/2020
Morningstar rated the Lord Abbett Developing Growth Fund class A share 5, 4 and 4 stars among 577, 512 and 382 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 8/31/2020, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Fund Basicsas of 08/31/2020
- Total Net Assets
- $2.81 B
- Inception Date
- 10/10/1973
- Dividend Frequency
- Annually
- Number of Holdings
- 97
- Minimum Initial Investment
- $1,000+
Expense Ratioas of 08/31/2020
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 31.79% | 28.69% | 27.24% | 16.38% | 17.44% | 11.31% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.91% | 19.87% | 14.44% | 12.25% | 14.24% | - |
| Russell 2000® Growth Index | 6.15% | 17.28% | 10.90% | 10.45% | 14.08% | - |
| w/ sales charge | 24.20% | 21.29% | 24.76% | 15.01% | 16.74% | 11.17% |
Fund Expense Ratio :
0.94%
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 16.81% | 11.21% | 23.11% | 11.15% | 16.24% | 11.07% |
| Lipper Category Avg. Small-Cap Growth Funds | 1.19% | 5.49% | 11.00% | 8.64% | 13.15% | - |
| Russell 2000® Growth Index | -3.06% | 3.48% | 7.86% | 6.86% | 12.92% | - |
| w/ sales charge | 10.08% | 4.81% | 20.71% | 9.84% | 15.55% | 10.93% |
Fund Expense Ratio :
0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 08/31/2020View Portfolio
| Holding | Assets |
|---|---|
| Fiverr International Ltd | 2.3% |
| Redfin Corp | 2.3% |
| Five9, Inc. | 2.2% |
| Inphi Corp. | 2.2% |
| iRhythm Technologies, Inc. | 2.1% |
| Generac Holdings, Inc. | 2.0% |
| Inspire Medical Systems Inc | 1.9% |
| LGI Homes, Inc. | 1.8% |
| Wingstop, Inc. | 1.8% |
| Helen of Troy Ltd. | 1.6% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2020View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Managing Director, Director of Equities and Portfolio Manager
21 Years of Industry Experience
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 31.79% | 28.69% | 27.24% | 16.38% | 17.44% | 11.31% |
| Lipper Category Avg. Small-Cap Growth Funds | 11.91% | 19.87% | 14.44% | 12.25% | 14.24% | - |
| Russell 2000® Growth Index | 6.15% | 17.28% | 10.90% | 10.45% | 14.08% | - |
| w/ sales charge | 24.20% | 21.29% | 24.76% | 15.01% | 16.74% | 11.17% |
Fund Expense Ratio :
0.94%
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 16.81% | 11.21% | 23.11% | 11.15% | 16.24% | 11.07% |
| Lipper Category Avg. Small-Cap Growth Funds | 1.19% | 5.49% | 11.00% | 8.64% | 13.15% | - |
| Russell 2000® Growth Index | -3.06% | 3.48% | 7.86% | 6.86% | 12.92% | - |
| w/ sales charge | 10.08% | 4.81% | 20.71% | 9.84% | 15.55% | 10.93% |
Fund Expense Ratio :
0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2019 | 31.91% | 28.48% |
| 2018 | 5.09% | -9.31% |
| 2017 | 29.92% | 22.17% |
| 2016 | -2.71% | 11.32% |
| 2015 | -8.90% | -1.38% |
| 2014 | 3.25% | 5.60% |
| 2013 | 57.19% | 43.30% |
| 2012 | 10.39% | 14.59% |
| 2011 | -1.66% | -2.91% |
| 2010 | 36.54% | 29.09% |
| 2009 | 47.03% | - |
| 2008 | -47.50% | - |
| 2007 | 35.83% | - |
| 2006 | 12.45% | - |
| 2005 | 11.87% | - |
| 2004 | 6.00% | - |
| 2003 | 40.06% | - |
| 2002 | -29.54% | - |
| 2001 | -6.98% | - |
| 2000 | -17.69% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2020 | -16.91% | 40.59% | - | - | 28.53% |
| 2019 | 27.01% | 9.09% | -11.35% | 7.39% | 31.91% |
| 2018 | 7.16% | 14.97% | 12.18% | -23.96% | 5.09% |
| 2017 | 8.36% | 4.06% | 7.07% | 7.61% | 29.92% |
| 2016 | -10.30% | 2.24% | 10.87% | -4.32% | -2.71% |
| 2015 | 7.12% | 2.61% | -15.70% | -1.68% | -8.90% |
| 2014 | 1.67% | 0.15% | -5.75% | 7.59% | 3.25% |
| 2013 | 13.50% | 10.00% | 18.78% | 6.00% | 57.19% |
| 2012 | 12.16% | -2.68% | 5.55% | -4.19% | 10.39% |
| 2011 | 10.23% | 1.49% | -20.86% | 11.06% | -1.66% |
| 2010 | 8.21% | -7.94% | 16.47% | 17.68% | 36.54% |
| 2009 | -2.17% | 24.37% | 14.25% | 5.76% | 47.03% |
| 2008 | -21.82% | 6.65% | -11.81% | -28.60% | -47.50% |
| 2007 | 4.65% | 13.60% | 9.82% | 4.04% | 35.83% |
| 2006 | 15.98% | -6.23% | -6.80% | 10.93% | 12.45% |
| 2005 | -5.91% | 5.82% | 9.60% | 2.52% | 11.87% |
| 2004 | 2.00% | 0.20% | -7.05% | 11.58% | 6.00% |
| 2003 | -3.27% | 21.33% | 9.79% | 8.70% | 40.06% |
| 2002 | 0.07% | -11.90% | -23.81% | 4.90% | -29.54% |
| 2001 | -17.44% | 16.01% | -22.68% | 25.62% | -6.98% |
| 2000 | 3.52% | -13.67% | -0.56% | -7.37% | -17.69% |
| 1999 | 1.42% | 11.69% | -3.37% | 26.23% | 38.16% |
| 1998 | 11.49% | -2.94% | -22.00% | 28.29% | 8.27% |
| 1997 | -2.88% | 17.68% | 21.77% | -6.03% | 30.78% |
| 1996 | 8.18% | 8.18% | -2.85% | 7.46% | 22.19% |
| 1995 | 6.04% | 19.02% | 15.90% | -0.42% | 45.66% |
| 1994 | 0.16% | -8.07% | 10.54% | 4.34% | 6.20% |
| 1993 | -0.67% | 1.03% | 8.15% | 3.76% | 12.62% |
| 1992 | -2.92% | -13.34% | 5.39% | 9.32% | -3.06% |
| 1991 | 29.96% | -5.07% | 9.77% | 15.46% | 56.36% |
| 1990 | 1.18% | 11.38% | -24.62% | 10.17% | -6.41% |
| 1989 | 3.04% | 1.70% | 8.07% | 0.77% | 14.12% |
| 1988 | 8.71% | 2.49% | -4.04% | -3.23% | 3.45% |
| 1987 | 23.22% | -1.54% | 5.33% | -21.15% | 0.76% |
| 1986 | 12.02% | 1.82% | -18.44% | 7.95% | 0.42% |
| 1985 | 9.91% | -2.42% | -9.28% | 18.16% | 14.96% |
| 1984 | -15.56% | -5.27% | 1.63% | -4.54% | -22.39% |
| 1983 | 19.37% | 16.69% | -4.44% | -6.33% | 24.68% |
| 1982 | -11.29% | 1.28% | 11.66% | 29.18% | 29.58% |
| 1981 | 6.38% | 7.72% | -18.09% | 14.79% | 7.74% |
| 1980 | -8.32% | 13.37% | 24.22% | 5.17% | 35.80% |
| 1979 | 11.23% | 3.38% | 10.21% | 1.23% | 28.29% |
| 1978 | 12.74% | 18.50% | 11.85% | -9.31% | 35.51% |
| 1977 | -5.21% | 6.36% | 3.99% | 7.90% | 13.12% |
| 1976 | 25.90% | -5.36% | -5.21% | 5.87% | 19.57% |
| 1975 | 36.09% | 17.79% | -12.76% | -0.65% | 38.93% |
| 1974 | 2.02% | -14.31% | -23.96% | -3.25% | -35.69% |
| 1973 | - | - | - | - | -9.00% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 08/31/2020
The chart begins on the Fund's inception date of 10/10/1973.
Based on a hypothetical Class A share investment of $10,000 on 10/10/1973 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Fiverr International Ltd | Consumer Discretionary | 2.3% |
| Redfin Corp | Real Estate | 2.3% |
| Five9, Inc. | Information Technology | 2.2% |
| Inphi Corp. | Information Technology | 2.2% |
| iRhythm Technologies, Inc. | Health Care | 2.1% |
| Generac Holdings, Inc. | Industrials | 2.0% |
| Inspire Medical Systems Inc | Health Care | 1.9% |
| LGI Homes, Inc. | Consumer Discretionary | 1.8% |
| Wingstop, Inc. | Consumer Discretionary | 1.8% |
| Helen of Troy Ltd. | Consumer Discretionary | 1.6% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Inphi Corp. | Information Technology | 2.7% |
| Five9, Inc. | Information Technology | 2.2% |
| Redfin Corp | Real Estate | 2.2% |
| LGI Homes, Inc. | Consumer Discretionary | 2.0% |
| Fiverr International Ltd | Consumer Discretionary | 1.9% |
| SVMK Inc | Information Technology | 1.9% |
| Wingstop, Inc. | Consumer Discretionary | 1.9% |
| Generac Holdings, Inc. | Industrials | 1.8% |
| Stamps.com, Inc. | Consumer Discretionary | 1.7% |
| Inspire Medical Systems Inc | Health Care | 1.7% |
| YETI Holdings Inc | Consumer Discretionary | 1.6% |
| Everbridge, Inc. | Information Technology | 1.6% |
| Repligen Corp. | Health Care | 1.5% |
| Restoration Hardware Holdings, Inc. | Consumer Discretionary | 1.5% |
| MKS Instruments, Inc. | Information Technology | 1.5% |
| Boston Beer Co., Inc. | Consumer Staples | 1.5% |
| Helen of Troy Ltd. | Consumer Discretionary | 1.5% |
| Axon Enterprise, Inc. | Industrials | 1.4% |
| Goosehead Insurance Inc | Financials | 1.4% |
| Immunomedics, Inc. | Health Care | 1.4% |
| Globant SA | Information Technology | 1.4% |
| Tandem Diabetes Care, Inc. | Health Care | 1.4% |
| Evoqua Water Technologies Corp | Industrials | 1.4% |
| Deckers Outdoor Corp. | Consumer Discretionary | 1.4% |
| National Vision Holdings Inc | Consumer Discretionary | 1.3% |
| Nevro Corp. | Health Care | 1.3% |
| Malibu Boats, Inc. | Consumer Discretionary | 1.3% |
| Mirati Therapeutics, Inc. | Health Care | 1.3% |
| Lumentum Holdings, Inc. | Information Technology | 1.3% |
| iRhythm Technologies, Inc. | Health Care | 1.3% |
| Trex Co., Inc. | Industrials | 1.2% |
| Arena Pharmaceuticals, Inc. | Health Care | 1.2% |
| Paylocity Holding Corp. | Information Technology | 1.2% |
| Acceleron Pharma, Inc. | Health Care | 1.2% |
| Blackline, Inc. | Information Technology | 1.2% |
| Monolithic Power Systems, Inc. | Information Technology | 1.2% |
| Penumbra, Inc. | Health Care | 1.1% |
| Q2 Holdings, Inc. | Information Technology | 1.1% |
| Appian Corp | Information Technology | 1.1% |
| Natera, Inc. | Health Care | 1.0% |
| Semtech Corp. | Information Technology | 1.0% |
| Vivint Solar, Inc. | Industrials | 1.0% |
| Federal Signal Corp. | Industrials | 1.0% |
| TG Therapeutics, Inc. | Health Care | 0.9% |
| Enphase Energy, Inc. | Information Technology | 0.9% |
| Chart Industries, Inc. | Industrials | 0.9% |
| Freshpet, Inc. | Consumer Staples | 0.9% |
| Winnebago Industries, Inc. | Consumer Discretionary | 0.9% |
| Vroom Inc | Consumer Discretionary | 0.9% |
| AZEK Co Inc/The | Industrials | 0.9% |
| Avalara Inc | Information Technology | 0.9% |
| Axonics Modulation Technologies Inc | Health Care | 0.9% |
| MyoKardia Inc | Health Care | 0.9% |
| Assetmark Financial Holdings Inc | Financials | 0.8% |
| Bridgebio Pharma Inc | Health Care | 0.8% |
| Endava PLC | Information Technology | 0.8% |
| Chegg, Inc. | Consumer Discretionary | 0.8% |
| FTI Consulting, Inc. | Industrials | 0.8% |
| CRISPR Therapeutics AG | Health Care | 0.8% |
| Limelight Networks, Inc. | Information Technology | 0.8% |
| ChemoCentryx Inc | Health Care | 0.8% |
| Sprout Social Inc | Information Technology | 0.8% |
| Grocery Outlet Holding Corp | Consumer Staples | 0.7% |
| CEVA, Inc. | Information Technology | 0.7% |
| frontdoor Inc | Consumer Discretionary | 0.7% |
| XPO Logistics, Inc. | Industrials | 0.7% |
| Blueprint Medicines Corp. | Health Care | 0.7% |
| Iovance Biotherapeutics Inc | Health Care | 0.6% |
| Turning Point Therapeutics Inc | Health Care | 0.6% |
| Constellation Pharmaceuticals Inc | Health Care | 0.6% |
| Guardant Health Inc | Health Care | 0.6% |
| Rocket Pharmaceuticals Inc | Health Care | 0.6% |
| Argenx SE | Health Care | 0.6% |
| Jamf Holding Corp | Undefined | 0.6% |
| Cirrus Logic, Inc. | Information Technology | 0.6% |
| Strategic Education, Inc. | Consumer Discretionary | 0.6% |
| Emergent Biosolutions, Inc. | Health Care | 0.6% |
| Qualys, Inc. | Information Technology | 0.6% |
| 2U, Inc. | Information Technology | 0.5% |
| Alteryx Inc | Information Technology | 0.5% |
| Schrodinger Inc/United States | Health Care | 0.5% |
| Calix Networks, Inc. | Information Technology | 0.5% |
| Mine Safety Appliance Co. | Industrials | 0.5% |
| Karuna Therapeutics Inc | Health Care | 0.5% |
| GW Pharmaceuticals plc | Health Care | 0.5% |
| Shift4 Payments Inc | Information Technology | 0.5% |
| Deciphera Pharmaceuticals Inc | Health Care | 0.5% |
| RealReal Inc/The | Consumer Discretionary | 0.5% |
| Cardlytics Inc | Information Technology | 0.5% |
| Invitae Corp | Health Care | 0.4% |
| Silicon Laboratories, Inc. | Information Technology | 0.4% |
| Allogene Therapeutics Inc | Health Care | 0.4% |
| Myovant Sciences Ltd | Health Care | 0.4% |
| Coherus Biosciences, Inc. | Health Care | 0.4% |
| Yext Inc | Information Technology | 0.3% |
| Zymeworks Inc | Health Care | 0.3% |
| Relay Therapeutics Inc | Health Care | 0.2% |
| Berkeley Lights Inc | Health Care | 0.2% |
| Lemonade Inc | Financials | 0.2% |
| nCino Inc | Information Technology | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 08/31/2020
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.2%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
0.3%
|
|
| Consumer Staples |
0.8%
|
|
| Energy | 0.0% | |
| Financials |
1.2%
|
|
| Health Care |
3.4%
|
|
| Industrials | 0.0% | |
| Information Technology |
1.0%
|
|
| Materials | 0.0% |
Portfolio Details as of 08/31/2020
- Total Net Assets
- $2.81 B
- Number of Holdings
- 97
- Weighted Average Market Cap.
- 5.0 B
- P/B Ratio
- 8.1x
- P/E Ratio
- 37.5x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 06/30/2020
Contributors
| Holding | Contribution |
|---|---|
| Redfin Corp | 2.2% |
| Yeti Hldgs Inc | 1.7% |
| Chegg, Inc. | 1.6% |
| Inphi Corp. | 1.3% |
| Svmk Inc | 1.2% |
Detractors
| Holding | Contribution |
|---|---|
| eHealth, Inc. | -0.7% |
| Constellation Pharmceti | -0.3% |
| Nextcure Inc | -0.2% |
| FTI Consulting, Inc. | -0.1% |
| Myokardia Inc | -0.1% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Developing Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 09/24/2020
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 02/14/1997 | 02/18/1997 | 03/03/1997 | $0.00000 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2020 | 11/24/2020 | 11/24/2020 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/20/2019 | 11/21/2019 | $4.4885 | - | $4.4885 | $18.77 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/23/2020 | 11/24/2020 |
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 09/24/2020
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $26.77 |
| $50,000 to $99,999 | 4.75% | 4.00% | $26.49 |
| $100,000 to $249,999 | 3.95% | 3.25% | $26.27 |
| $250,000 to $499,999 | 2.75% | 2.25% | $25.94 |
| $500,000 to $999,999 | 1.95% | 1.75% | $25.73 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $25.23 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 08/31/2020
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||